UNC Institute for Global Health & Infectious Diseases | SAP Partner

Jonathan Parr, MD, MPH, discusses his research around this deadly and burdensome disease and how they identify these parasitic strains with a combination of epidemiologic field work and the latest laboratory technology.

UNC’s Sarah Rutstein, MD, PhD, discusses her research uncovering the inability of some people to receive HIV prevention medication in both the US and Africa and strategies in how to address it.

Joseph Eron, MD, provides insights on their international reach as well as some of the important trials they have been involved in, notably the PURPOSE studies involving the landmark trials around lenacapavir for HIV prevention.

UNC’s Benjamin Smith, MD, provides some insights into the logistics and steps behind these complicated and serious missions.

Leaders from the UNC Special Pathogens Response Center discuss how they plan and carry out biopreparedness trainings to address transport and care of patients with high-consequence infectious diseases, such as Ebola or Lassa fever.

The University of North Carolina (UNC) Institute for Global Health and Infectious Diseases Director Myron Cohen, MD, discusses the uniqueness of the institution and its ability to offer research and clinical opportunities globally as well as play a significant role in public health.

Dr. Arlene Sena and her team are working to develop a syphilis vaccine, “But we need to know what’s circulating worldwide first.”